Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage "DFO In ICH"


Phase 1 Results N/A

Summary of Purpose

Animal studies show that the breakdown of blood results in iron accumulation in the brain after brain hemorrhage (ICH); and that iron plays a role in brain injury in ICH patients. Deferoxamine (DFO) has been extensively used in clinical practice for more than 30 years to remove excessive iron from the body, and has been shown to provide some benefit in animal studies of ICH. Therefore, we plan to undertake this...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 11 January 2018.

1 Jul 2008 10 Jan 2008 1 Jan 2010 1 Apr 2010 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available